Electric pulses and diet: a new weapon against muscle loss in stomach and bowel cancers?
NCT ID NCT06414122
First seen Jul 27, 2026 · Last updated Jul 27, 2026
Summary
This trial tests whether a combination of whole-body electromyostimulation (WB-EMS) — a technology that uses electrical impulses to make muscles contract — and nutritional therapy can help people with certain gastrointestinal cancers preserve muscle mass. Participants include those with esophageal, stomach, duodenal, or colorectal cancer who have had surgery. The study compares WB-EMS plus nutritional coaching against conventional exercise and nutritional advice over 12 weeks.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- mid-frequency whole-body electromyostimulation (WB-EMS) combined with nutritional therapy
- What this could lead to
- If effective, this approach could offer a drug-free way to help people with gastrointestinal cancers maintain muscle mass and physical function during and after treatment.
- What could go wrong
- This is a relatively small, early-stage trial. The benefits of WB-EMS for muscle preservation in this specific cancer population are not yet proven, and the training requires medical clearance and may not be suitable for everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLON CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Universitätsklinikum Köln, Centrum für Integrierte Onkologie (CIO)
Cologne, North Rhine-Westphalia, 50937, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Three-Drug cocktail shrink stomach tumors before surgery?
- Can we predict who will survive a bowel surgery leak?
- Can a new nucleotide analogue boost cancer treatment?
- Can a Two-Drug attack shrink Hard-to-Treat colorectal tumors?
- Rearranging the treatment timeline: could a new sequence of chemo and radiation spare rectal cancer patients from major surgery?
- Rectal cancer: could a 'Watch and Wait' strategy spare patients from major surgery?